These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24748380)

  • 1. Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.
    Yang Y; Rhodus NL; Ondrey FG; Wuertz BR; Chen X; Zhu Y; Griffin TJ
    PLoS One; 2014; 9(4):e95389. PubMed ID: 24748380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma.
    Wen J; Nikitakis NG; Chaisuparat R; Greenwell-Wild T; Gliozzi M; Jin W; Adli A; Moutsopoulos N; Wu T; Warburton G; Wahl SM
    Am J Pathol; 2011 Jun; 178(6):2866-78. PubMed ID: 21641406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma.
    Wang X; Jin Y; Li YX; Yang Y
    Oncol Rep; 2018 Apr; 39(4):1793-1804. PubMed ID: 29436667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
    Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
    Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
    Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
    Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the potential of a novel oral lesion exudate collection method coupled with mass spectrometry-based proteomics for oral cancer biomarker discovery.
    Kooren JA; Rhodus NL; Tang C; Jagtap PD; Horrigan BJ; Griffin TJ
    Clin Proteomics; 2011 Sep; 8(1):13. PubMed ID: 21914210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
    Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
    Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion.
    Mikami Y; Fukushima A; Komiyama Y; Iwase T; Tsuda H; Higuchi Y; Hayakawa S; Kuyama K; Komiyama K
    Cancer Lett; 2016 Aug; 379(1):84-93. PubMed ID: 27238568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
    Ghallab NA; Shaker OG
    Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
    Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary proteomics for oral cancer biomarker discovery.
    Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
    Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
    Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
    Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.
    Nittayananta W; Kemapunmanus M; Yangngam S; Talungchit S; Sriplung H
    J Oral Pathol Med; 2013 Mar; 42(3):208-15. PubMed ID: 23126266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
    Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
    Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo.
    Devoogdt N; Rasool N; Hoskins E; Simpkins F; Tchabo N; Kohn EC
    Cancer Sci; 2009 Mar; 100(3):434-40. PubMed ID: 19154415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.
    Dickey BL; Sirak B; Martin-Gomez L; Reich RR; Abrahamsen M; Isaacs-Soriano K; Chung CH; Giuliano AR
    PLoS One; 2021; 16(7):e0254161. PubMed ID: 34214131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
    Choi BD; Jeong SJ; Wang G; Park JJ; Lim DS; Kim BH; Cho YI; Kim CS; Jeong MJ
    Int J Mol Med; 2011 Oct; 28(4):527-34. PubMed ID: 21687932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer.
    Cheng WL; Wang CS; Huang YH; Liang Y; Lin PY; Hsueh C; Wu YC; Chen WJ; Yu CJ; Lin SR; Lin KH
    Int J Cancer; 2008 Oct; 123(8):1787-96. PubMed ID: 18688858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
    Zhang X; Liu SS; Ma J; Qu W
    Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.